论文部分内容阅读
随着人们生活水平的不断提高及医学影像学、病理学、细胞生物学技术的飞速发展,近年来随着双原发性肺癌(double primary lung cancer,DPLC)发病率的迅速增长,胸外科医务工作者们也在不断的完善诊治标准。目前,多指标联合诊断、根据单个病灶进行临床分期、早期进行手术治疗已被大多数胸外科医生所接受,电视胸腔镜手术(video-assisted thoracoscopic surgery,VATS)因其创伤小等优势,逐渐被胸外科医生认可,获得广泛应用,是未来DPLC乃至整个胸部疾病手术治疗的发展方向。此外,单纯的放疗已被证实预后和手术治疗没有明显差异,胸外科传统的观念正在受着严峻的挑战。现将双原性发肺癌的临床诊治进展综述如下。
With the continuous improvement of people’s living standards and the rapid development of medical imaging, pathology and cell biology techniques, with the rapid increase of the incidence of double primary lung cancer (DPLC) in recent years, thoracic surgeons The authors are also constantly improve the diagnosis and treatment standards. At present, multi-index combined diagnosis, according to a single lesion for clinical staging, early surgical treatment has been accepted by most thoracic surgeons, video-assisted thoracoscopic surgery (VATS) due to its trauma and other advantages, gradually being Thoracic Surgeons approved, widely used, is the future development of surgical treatment of DPLC and thoracic diseases. In addition, radiotherapy alone has been proved no significant difference between the prognosis and surgical treatment, the traditional concept of thoracic surgery is now under serious challenges. Now the clinical diagnosis and treatment of lung cancer double progress are summarized as follows.